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ABSTRACT
Background : Patients with long
standing DM undergoing surgical interventions are put under great challenge as they may have cardiovascular
and/or
cardiac
autonomic
neuropathy (CAN). CAN is serious,
often overlooked and under diagnosed, with possible arrhythmias
and silent ischemia that threaten life.
Objectives: Screening for one of the
under diagnosed high risk problem
by assessment of CAN in long standing type 2 diabetic women undergoing stressful situations. Study design: Cross section study. Patients
and methods: 100 type 2 diabetic
women scheduled for major surgery
were assessed by the autonomic
function tests. CAN was assessed by
analyzing HR variations during three
standard tests (deep breathing, lying
25
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to standing and valsalva maneuver).
Sympathetic functions were assessed by checking orthostatic hypotension. The CAN score of each patient was analyzed. Continuous 24
hours ECG monitoring (Holter) to
evaluate arrhythmia, QTc and QTd.
Transthoracic Doppler echocardiography, stressing on LVH, diastolic
and systolic dysfunctions were carried out. Cases were classified as
mild (with only one abnormal test) or
severe CAN when 2 or more abnormal function tests were present. Exclusion criteria include any systemic
illness that can affect the study results or the autonomic functions,
smoking, hypertension and cases
with evident ischemia. Results: CAN
was detected in 70% of the studied
cases, and 70% was severe CAN.
Postural hypotension was detected
MANSOURA MEDICAL JOURNAL
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in 34% of the studied cases. QTc
prolongation and QT dispersion were
frequent. ECG and Doppler echocardiography changes of LVH were
more prevalent among patients with
CAN. Diabetics with CAN were significantly older had longer duration of
DM and higher HbA1-c, higher pulse
pressure, triglyceride, uric acid and
urinary albumin execration rate.
They also had significant increased
LVM index and diastolic dysfunction.
Conclusion: Middle aged women
with long standing diabetes are vulnerable to CAN with postural hypotension and prolonged QTc intervals,
QT dispersion, and increased LVMI.
Identification of CAN is crucial to exercise prevention against hazards of
CV insults during stressful situation
and cases with severe CAN may be
in need for CAD screening preoperatively.
Key word : cardiac autonomic
neuropathy.
Abbreviations: CAN: Cardiac autonomic neuropathy, LVH: Left ventricular hypertrophy, DM: Diabetes
mellitus, HTN: Hypertension.

INTRODUCTION
Autonomic neuropathy, although
not rare, is one of the most insidious
complications of diabetes mellitus

(DM) especially if long standing and
poorly controlled. Cardiac autonomic
neuropathy (CAN) is often overlooked both in diagnosis and treatment simply because there is no
widely accepted single approach to
its diagnosis (1). CAN embraces exercise intolerance, intraoperative cardiovascular liability, orthostatic syndromes and silent myocardial
ischemia (2, 3, 4). These clinical manifestations can result in life threatening outcome which unquestionably
associate the presence of CAN with
the increased risk of CV morbidity
and mortality in DM.
In Eurodiab prospective study
(2001) CAN was among the strongest risk markers of future total and
CV mortality exceeding the effect of
traditional risk factors as age, obesity, hypertension, dyslipidemia, inflammatory
and
prothrombotic
emerging cardiac risk factor (4, 5). In
a Meta analysis of 12 published
studies Vinik et al (2003) (6) reported
a constant association between CAN
and silent myocardial ischemia and
in DIAD study, CAN was a stronger
predictor of silent ischemia and subsequent cardiac events (7).
QTc interval and QTd have been
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considered as a marker of cardiac
autonomic dysfunction and have
been demonstrated as an independent predictor of CV mortality and all
cause mortality risk in type 2 DM patients (4). Combined abnormality in
HRV and QT index was a strong predictor of mortality independent of
conventional risk factor (8, 9).
Action to Control Cardiovascular
Risk in Diabetes (ACCORD trial
2010) in the presence of CAN at
baseline was an independent contributor to the higher CV mortality
risk in both the intensive and standard glycemic arm treatment. Individuals with baseline CAN were two
times more likely to die compared
with individuals without CAN (10, 11).
A lot of attention has been given to
the CV aspect of autonomic dysfunction especially with the view regarding very tight glycemic control with
increased mortality ACCORD trial
(12) attributed increased mortality to
hypoglycemia induced arrhythmias
(1).
There is no widely accepted single approach to the diagnosis of
CAN, however during the 1970s Ewing et al (1980) (13), advised a number of simple bedside tests of short

27

term RR difference to detect CAN including changes in RR with deep
breathing, RR response to standing
which induce reflex tachycardia followed by bradycardia and Valsalva
ratio which evaluates cardiovagal
function in response to standard increase in intrathorathic pressure.
Orthostatic hypotension with its
many troublesome symptoms ranging from light headedness to near
syncope that may be associated with
poor quality of life with fall in systolic
BP ≥ 20 mmHg and ≥10 mmHg in diastolic BP during 3 minutes of standing and resolving with sitting or lying
down is characteristic of CAN (14,
15).
The clinical symptoms of CAN
may be late, however subclinical
CAN manifest as changes in HRV
may be detected within one year of
diagnosis of type 2 DM (16).
Pop Bussi (2010) (17), reported
that screening for CAN revealed that
it ranges from as low as 2.5%
(DCCT) to as high as 90% in long
standing DM and should be instituted at diagnosis of type 2 DM and after 5 years of diagnosis of type 1
(18). Vinik and Ziegler (2007) (19), reMANSOURA MEDICAL JOURNAL
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ported that, detection of CAN is a
must before exposing patients with
long standing DM to stressful situation and also before planning exercise. Diabetics must be tested with a
cardiac stress test before undergoing an exercise program. Patients
with CAN need to rely on their perceived exertion and not heart rate to
avoid the hazardous levels of exercise intensity (19).

duration of DM was 10± 2 years
ranging from (6- 14 years). BMI
ranging from 25.1 to 29.2 (mean
27.1± 1.1).
All medications that can affect the
study results or the autonomic functions were withhold during and one
week preceding the clinical assessment of autonomic functions.

Aims : Screening and assessment of cardiac autonomic dysfunction in middle aged women with long
standing type 2 DM who are going to
be exposed to stress in the form of
major surgery.

Examinations were undertaken in
the morning at least 2 hours after a
light breakfast and no caffeine was
allowed. The patients were asked
about symptoms suggestive of autonomic neuropathy, postural hypotension and myocardial ischemia.

Design : Cross- section study.
Subjects and Methods : The
studied cases included one hundred
and six women who are known to be
diabetics and were under oral hypoglycemic agents (70 cases) and 36
cases were under combined insulin
and sulphonylurea. All were receiving metfornin 1.7 gm/ day. Six cases
did not complete the study for unknown reasons and only 100 cases
completed the study. Their age
ranged from 40 to 60 years (mean
52.4± 3.7 years). The studied cases
had no polys symptoms. The mean

Diabetic complications as retinopathy were checked and peripheral
neuropathy, sudomotor neuropathy
was stressed upon. Peripheral neuropathy and sudomotor neuropathy
were detected clinically by monofilament and dryness of the feet. Clinical examination, with stress on heart
rate, SBP, DBP, pulse pressure was
undertaken, Testing of autonomic
parasympathetic dysfunction was assessed by HRV testing (heart rate
ECG RR intervals on resting, standing, respiration and valsalva). Heart
rate variability was calculated from
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the RR interval using short continuous ECG recording. Continuous 24
hours ECG monitoring (Holter) was
also used to evaluate ischemia, arrhythmia, QTc intervals and QTd.
Cases with evident ischemia or arrhythmias were not included. The
resting 12 lead ECG was also undertaken to show beside HRV evidences of LVH and/or ischemia. Prolongation of the QTc interval > 460 ms,
and QTd > 10 ms were considered
as evidences of HRV. Flattening of T
wave and ST segment depression
were considered as evidences of
myocardial ischemia. Cases with angina ECG, Holter monitor evidences
of ischemia were not included in the
screening study.
Testing for sympathetic dysfunction by postural hypotension in supine and after standing for 3 minutes
was undertaken with the standard
mercury sphygmomanometer. The
measurement in the supine position
was taken after at least 15 minutes
of rest and measurement in standing
position was taken at the third minute of standing.
Transthoracic Doppler echocardiography was done stressing on
LVMI, diastolic and systolic dysfunc-

29

tions were carried out.
Biochemical studies were undertaken stressing on blood glucose,
fasting and post 75 gm glucose challenge together with HbA1-c, serum
creatinine, plasma cholesterol, triglyceride, serum uric acid and 24 hours
urine albumin excretion.
The prevalence and the severity
of CAN was assessed according to
the number of autonomic function
tests of Ewing’s methodology, and
the CAN score in each patient was
analyzed.
Subclinical CAN cases or mild
CAN with only one abnormal function
test were compared to severe CAN
cases (2 or 3 abnormal autonomic
function).
The study protocol was approved
by the scientific committee of Mansoura Faculty of Medicine and informed consents were obtained.
Exclusion criteria : Systemic illness that can affect the study results
or the autonomic functions as CHF,
CAD, arrhythmia, renal, hepatic impairment, HCV infection, severe anemia, thyroid dysfunction, smoking,
MANSOURA MEDICAL JOURNAL
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concomitant treatment with anticholinergic agents, adrenergic antagonists, vasoconstrictive agents and
patients with BP≥ 140/90 mmHg on
two occasions 2 weeks apart were
not included.
Statistical analysis : was performed by using the statistical package for social science program
(SPSS) version "16". The qualitative
data were presented as frequency
and percentages. The quantitative
data were examined by using Kalmogrov-Smirnov test to test for normal
distribution of the data and when
parametric, expressed as mean and
standard deviation. Student t test
was used, to test for difference in
normally distributed quantitative data
between the two groups. MannWhitney-µ test was used for comparison between two groups when data
are not normally distributed. Significance was considered when P value
less than 0.05.

lying flat, valsalva maneuver, were
70% (20 cases with single HRV testing, 26 cases with 3 HRV testing,
and 24 cases with moderate CAN
where two HRV tests were present).
Postural hypotension was detected in 34% of the studied cases and
mean pulse pressure were significantly elevated in diabetic with CAN
when compared to those without
CAN (P < 0.01).
Prolonged QTc (> 460 ms) in
42% of the whole studied cases and
60% of the CAN cases and significantly increased QTd (> 10 ms) in
the CAN group when compared to
the non CAN group as evident by the
continuous 24 hrs ECG Holter monitoring.
Women with DM and CAN were
significantly older with significant
longer duration of uncontrolled DM
with insignificant differences in BMI.

RESULTS
The prevalence of CAN as assessed by signs of autonomic neuropathy including HRV tests E/I ratio
(expiration to inspiration) standing to

There was no significant difference in the prevalence of CAN in relation to the method of controlling hyperglycemia (oral versus combined
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oral hypoglycemic and insulin).

functions.

Symptoms suggestive of CAN in
other systems, mainly urogenital
were evident in the CAN group
(P<0.04). Peripheral neuritis detected by monofilament with dryness of
their feet (P<0.01). SBP, DBP and
the mean pulse pressure were significantly higher in the CAN group (P <
0.001).

Significantly higher BG level and
HbA1-c in the CAN group was observed, with significant hypertriglyceridemia and elevation in uric acid
in the CAN group. The urinary albumin excretion in the CAN was significantly elevated than in non CAN
group (P< 0.01).Comparing the studied parameters in relation to the severity of CAN showed insignificant
changes apart from significant older
age, more postural hypotension,
HbA1-c, serum creatinine, urine albumin excretion and QTc. Signs of
LVH and QTd revealed borderline
significant increase in severe CAN
cases.

Transthoracic echo Doppler revealed presence of mild LVH (LV
wall mass index ≥ 126 gm/ m2 in
70.01% of CAN versus 33.3% in the
non CAN group P < 0.001) and significant abnormal relaxation pattern
(E/A < 1) with preserved LV systolic

MANSOURA MEDICAL JOURNAL
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DISCUSSION
It was aimed in the present
screening study to evaluate the CAN
in middle aged women with long
standing diabetes scheduled for
stressful situation in the form of major surgery. Detection of CAN preoperatively is necessary as such patients are vulnerable to perioperatve
cardiovascular instability with a
greater decline in heart rate and BP
during induction of anesthesia and
more severe hypothermia (19, 3).

neuver procedure and lowest (20%)
by the diminished expiration to inspiration ratio (E/I ratio) and by standing to laying flat. The scoring of CAN
was calculated, where more than
one fourth (26%) had ≥ 3 positive
tests and 24% had ≥ 2 positive. This
is in accordance with Katsilamborus
et al (2011) (1), who found that autonomic neuropathy and CAN are not
at all rare, but are often overlooked.

In the present study, the prevalence of CAN as detected by Ewings
et al 1970s proposals of heart rate
variability tests (Ewings et al 1980)
was high (70%). As the determination of CAN is usually based on a
battery of autonomic function test
and as the proceeding from a consensus conference (1992) (20), recommended three tests. In the
present study, the golden standard
clinical autonomic testing (21) was
followed (Expiration/inspiration ratio,
standing to lying flat and valsalva
maneuver and postural hypotension)

The prevalence of CAN ranged
from as low as 2.5% (DCCT) (17) to
as high as 90% in long standing DM
and in 69% of treatment induced
neuropathy (22). In the present study
the valsalva ratio was 30% and E/I
ratio was 20%. Our results are not in
accordance with England and coworkers (2009) (23), who found that
HRV with deep breathing is the most
widely used test of cardiovagal parasympathetic dysfunction. Cardiovascular sympathetic function was assessed by measuring the BP
response to orthostatic changes (24,
25) and was detected in 34% of the
studied cases.

The prevalence of CAN ranged
from 20% to 42% according to the
way of detecting HRV state being
highest (30%) by the valsalva ma-

The prevalence of CAN in the
present study is higher than that of
Zeigler et al 1992 (26), who by using
HRV tests found that 34.3% of type
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2 DM patients had abnormal functions. Similar to Cabezas- Cerrato et
al 2009 (27), the HR response to
deep breathing in the present study
was the least evident among the
studied cases.

reported the association of high serum uric acid level and sundomotor
dysfunction in patient with type 2 DM
and CAN. In the present study similarly serum uric acid showed significant differences.

In the present study, the studied
cases were all females this could
avoid gender related difference in biochemical and hematological values
(28, 29). CAN was more prevalent in
diabetic of longer duration, older age
those with more pulse pressure,
higher serum triglycerides and with
more elevated HbA1-c. Kodama et al
(2012) (30), in a Meta analysis study
described the association of pulse
pressure as a cardiovascular risk in
DM. Makimattila et al (2000) (31),
found that poor glycemic control was
the most important independent predictor of decrease in all measures of
absolute power of HRV.

Symptoms of orthostatic intolerance and gastrointestinal function,
urinary frequency, nocturia and anhydrosis were reported more frequently in diabetics with CAN. This is
in line with Gibons and Freeman
(2011) (33), although in the present
study only the urogenital symptoms
were significantly more frequent in
CAN group.

Our findings are also in agreement with those of Voulgari et al
2011(21) who mentioned that in type
2 DM patients, CAN has been independently associated with elevated
BP, hyperglycemia, longer diabetes
duration, dyslipidemia and the presence of microvascular complications
(32, 21). Katsilambors et al (2011) (1)

Peripheral
neuropathy
was
present in 80% of the examined cases. This is in agreement with Vinik
and Ziegler (2007) (34), Gandhi et al
(2010) (35) who found that combined
indices of autonomic and peripheral
neurological dysfunction is associated with earlier CAN detection (36,
37). In the EURODIAB (24) prospective complication study peripheral
and autonomic neuropathy was
among the strongest risk markers
exceeding the effects of the traditional risk factors.
Orthostatic hypotension was demMANSOURA MEDICAL JOURNAL
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onstrated in 34% of the whole studied cases and in 60% of the CAN
group. Orthostatic symptomatology
as light headedness, dizziness, fatigability, faintness on standing was
very frequent (60%). However no reported cases of clear or near syncope were reported. Orthostatic hypotension in CAN is secondary to
efferent sympathetic vasomotor denervation causing reduced vasoconstriction of the splanchinic and other
peripheral bed (20).
In the present study the resting
heart rate in the CAN group was
around 100 bpm but was insignificantly rapid than in the non CAN
group. This is in line with Pop-Bussi
(2010) (17) who stated that increased
resting heart rate is not a reliable diagnostic criterion for CAN in the absence of other signs.
In the present study QTc prolongation and the more prevalent QT
dispersion, are in agreement with
Voulgari et al (2011) (4). QTc interval was considered as a marker of
cardiac autonomic dysfunction and is
significantly associated with LVH (4).
The increase in the number of the
abnormal CAN function tests increase the risk more (38). Pappach-

en et al (2008) (39) concluded that
QTc interval can be used to diagnose CAN and the combined abnormality of HRV, QTc and QTd were
strong predictors of mortality independent of conventional risk factors
(40, 41).
Prolongation of QTc interval was
detected in 60% of the CAN cases.
This coincides with the finding of
Lombardi (2002) (42). LVH was significantly manifest in the CAN group
in comparison to the non CAN group.
In the present study QTc interval
prolongation (> 440 ms) has been
associated with increased age and
duration of DM, SBP, DBP, mean
pulse pressure and severity of autonomic neuropathy. This is in accordance with the finding of Ewing et al
(1991) (43) and Veglio et al 2000
(44).
Comparing mild CAN cases and
severe CAN cases revealed some
clinical, biochemical, electrocardiographic and echocardiographic significant differences including; older
age, more postural hypotension, elevated HbA1-c, serum creatinine,
urine 24 albumin excretion and more
frequent QTc prolongation which
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may impose more cardiovascular
risk.

CONCLUSION
CAN in women with type 2 DM
are common. Detection of CAN irrespective of its scoring in patient with
DM is of importance and can help to
exercise more precautions during
their diabetic management. As patients with prolonged QT intervals
are at higher risk of sudden cardiac
death, cases with sever CAN have to
be screened for CAD preoperatively
and special clinic for cardiac autonomic neuropathy may be warranted.
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